Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV Trifluridine/Tipiracil HRQoL in Metastatic Colorectal Cancer
DRKS00012977Phase 4Completed
- Sponsor
- Servier
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of trifluridine + tipiracil in metastatic colon cancer (mCRC), colon cancer, rectosigmoid cancer and 1 more, sponsored by Servier. Primary endpoint: Health-related quality of life. Started Sep 2017; status: completed.
02
Drugs
trifluridine + tipiracil
03
Conditions
metastatic colon cancer (mCRC)colon cancerrectosigmoid cancerrectal cancer
Beyond the preview
Go deeper on DRKS00012977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00012977.